SUGP vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

SUGP

30.6
AI Score
VS
NIVF Wins

NIVF

54.4
AI Score

Investment Advisor Scores

SUGP

31score
Recommendation
SELL

NIVF

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SUGP NIVF Winner
Revenue 24.72M 4.73M SUGP
Net Income -2.37M 9.88M NIVF
Gross Margin 16.0% 20.2% NIVF
Net Margin -9.6% 209.0% NIVF
Operating Income -2.57M -10.73M SUGP
ROE -21.5% 37.1% NIVF
ROA -14.7% 30.2% NIVF
Total Assets 16.18M 32.72M NIVF
Cash 3.26M 758,621 SUGP
Current Ratio 2.82 3.12 NIVF
Free Cash Flow -2.20M -11.06M SUGP

Relative Price Performance (Last 90 Days)

SUGP 1M: +237.9% · 3M: +236.8% NIVF 1M: -74.8% · 3M: -86.5%

Current Technical Phase

SUGP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (19.9% over 20 days), RSI 56

RSI (14): 55.6 · Price: $1.62

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -34.5%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $0.15

Fundamentals Snapshot

Metric SUGP NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% -1.8%
EPS -51.82 -4258.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.